These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7722439)

  • 1. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases.
    Wucherpfennig KW; Strominger JL
    J Exp Med; 1995 May; 181(5):1597-601. PubMed ID: 7722439
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA class II transgenic mice as models of human diseases.
    Taneja V; David CS
    Immunol Rev; 1999 Jun; 169():67-79. PubMed ID: 10450509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structure of human MHC class II genes.
    Rask L; Jonsson AK; Svensson AC; Gustafsson K; Andersson L
    Autoimmunity; 1991; 8(3):237-44. PubMed ID: 1932510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer.
    Jo YS; Lee JC; Li S; Choi YS; Bai YS; Kim YJ; Lee IS; Rha SY; Ro HK; Kim JM; Shong M
    Int J Cancer; 2008 Feb; 122(4):785-90. PubMed ID: 17957790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naturally processed peptides from HLA-DQ7 (alpha1*0501-beta1*0301): influence of both alpha and beta chain polymorphism in the HLA-DQ peptide binding specificity.
    Khalil-Daher I; Boisgérault F; Feugeas JP; Tieng V; Toubert A; Charron D
    Eur J Immunol; 1998 Nov; 28(11):3840-9. PubMed ID: 9842927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allele-specific methylation in the 5'-regulatory region of class II DQ beta genes in the human major histocompatibility complex (MHC): relationship to autoimmune disease susceptibility.
    Toyoda H; Redford A; Magalong D
    Dis Markers; 1992; 10(1):7-18. PubMed ID: 1424441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA class II polymorphism: implications for genetic susceptibility to autoimmune disease.
    Gregersen PK
    Lab Invest; 1989 Jul; 61(1):5-19. PubMed ID: 2664347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular basis of autoimmunity.
    McDevitt HO
    Clin Res; 1986 Apr; 34(2):163-75. PubMed ID: 3086018
    [No Abstract]   [Full Text] [Related]  

  • 9. Both alpha and beta chain polymorphisms determine the specificity of the disease-associated HLA-DQ2 molecules, with beta chain residues being most influential.
    Johansen BH; Jensen T; Thorpe CJ; Vartdal F; Thorsby E; Sollid LM
    Immunogenetics; 1996; 45(2):142-50. PubMed ID: 8952964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Binding-peptide motifs of HLA class II molecules susceptible to autoimmune diseases].
    Nishimura Y
    Nihon Rinsho; 1997 Jun; 55(6):1384-96. PubMed ID: 9200922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human collagen II peptide 256-271 preferentially binds to HLA-DR molecules associated with susceptibility to rheumatoid arthritis.
    Diab BY; Lambert NC; L'Faqihi FE; Loubet-Lescoulié P; de Préval C; Coppin H
    Immunogenetics; 1999 Jan; 49(1):36-44. PubMed ID: 9811967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA class II haplotype DRB1*04-DQB1*0301 contributes to risk of familial generalized vitiligo and early disease onset.
    Fain PR; Babu SR; Bennett DC; Spritz RA
    Pigment Cell Res; 2006 Feb; 19(1):51-7. PubMed ID: 16420246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma).
    Kuwana M; Kaburaki J; Okano Y; Inoko H; Tsuji K
    J Clin Invest; 1993 Sep; 92(3):1296-301. PubMed ID: 7690776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nucleotide sequence and evolution of ovine MHC class II B genes: DQB and DRB.
    Scott PC; Maddox JF; Gogolin-Ewens KJ; Brandon MR
    Immunogenetics; 1992; 35(3):217. PubMed ID: 1537613
    [No Abstract]   [Full Text] [Related]  

  • 15. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
    Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA
    J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome.
    Matsushita S; Takahashi K; Motoki M; Komoriya K; Ikagawa S; Nishimura Y
    J Exp Med; 1994 Sep; 180(3):873-83. PubMed ID: 8064238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different HLA-DR-DQ and MHC class I chain-related gene A (MICA) genotypes in autoimmune and nonautoimmune gestational diabetes in a Swedish population.
    Törn C; Gupta M; Sanjeevi CB; Aberg A; Frid A; Landin-Olsson M
    Hum Immunol; 2004 Dec; 65(12):1443-50. PubMed ID: 15603871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular organization of the class II genes of the human and mouse major histocompatibility complexes.
    Carson S; Trowsdale J
    Oxf Surv Eukaryot Genes; 1986; 3():63-94. PubMed ID: 2855304
    [No Abstract]   [Full Text] [Related]  

  • 19. Peptide-binding assays and HLA II transgenic Abeta degrees mice are consistent and complementary tools for identifying HLA II-restricted peptides.
    Depil S; Angyalosi G; Moralès O; Delacre M; Delhem N; François V; Georges B; Hammer J; Maillère B; Auriault C; Pancré V
    Vaccine; 2006 Mar; 24(13):2225-9. PubMed ID: 16469420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of conserved islet peptides by human and murine MHC class II molecules associated with susceptibility to type I diabetes.
    Yu B; Gauthier L; Hausmann DH; Wucherpfennig KW
    Eur J Immunol; 2000 Sep; 30(9):2497-506. PubMed ID: 11009082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.